1,412 results on '"Ferreira, Joaquim J."'
Search Results
2. Factors associated with self-rated health in people with late-stage parkinson’s and cognitive impairment
3. Meaning in Life in Late-Stage Parkinson’s Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries
4. Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
5. Correction to: Immune‑related serious adverse events with immune checkpoint inhibitors: systematic review and network meta‑analysis
6. List of contributors
7. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis
8. Direct oral anticoagulants vs vitamin K antagonist on dementia risk in atrial fibrillation: systematic review with meta-analysis
9. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
10. Atrial fibrillation risk on Parkinson’s disease – a systematic review and meta-analysis
11. Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
12. Basic concept of sensors for movement disorders specialists
13. COMT Inhibitors in the Management of Parkinson’s Disease
14. Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
15. Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis
16. Systematic reviews and meta-analysis published in indexed Portuguese medical journals: time trends and critical appraisal
17. The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis
18. Postural abnormalities in Asian and Caucasian Parkinson's disease patients: A multicenter study
19. The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's Disease.
20. Anticoagulation therapy in patients with post-operative atrial fibrillation: Systematic review with meta-analysis
21. Frequency of dementia in Parkinson's disease: A systematic review and meta-analysis
22. 3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS‐Unified Parkinson's Disease Rating Scale in Patients with Motor Complications
23. Efficacy of ND0612, a 24-hour Subcutaneous Levodopa/Carbidopa Infusion for People with Parkinson’s Disease Experiencing Motor Fluctuations: Subgroup-analyses from a Randomized, Controlled Phase 3 Study (S30.008)
24. Opicapone to Treat Early Wearing‐off in Parkinson's Disease Patients: The Korean ADOPTION Trial
25. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
26. Drooling rating scales in Parkinson's disease: A systematic review
27. Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
28. Characteristics of Patients with Late-Stage Parkinsonism Who are Nursing Home Residents Compared with those Living at Home
29. High frequency of psychosis in late-stage Parkinsońs disease
30. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
31. Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
32. Molecular characterization of the circadian clock in patients with Parkinson's disease–CLOCK4PD Study protocol.
33. Moving towards home-based community-centred integrated care in Parkinson's disease
34. Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis
35. Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis
36. Guidelines on exercise testing and prescription for patients at different stages of Parkinson’s disease
37. The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis
38. Meaning in Life in Late-Stage Parkinson’s Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries
39. Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis
40. Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities
41. Validation of quantitative gait analysis systems for Parkinson’s disease for use in supervised and unsupervised environments
42. Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease
43. Nocebo response in Parkinson's disease: A systematic review and meta-analysis
44. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?
45. Dysphagia predicts poor outcome in late-stage Parkinson's disease
46. Cognitive testing in late-stage Parkinson's disease: A critical appraisal of available instruments.
47. Reply to: From Unsolicited Medical Opinions to Viral Medical Discussions: is sharing caring?
48. Long-term follow-up of subthalamic nucleus deep brain stimulation in patients with Parkinson's disease: An analysis of survival and disability milestones
49. PROCare4Life lessons learned
50. Clinical Trials for Motor Complications in Parkinson’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.